Physician profile
Racheal E Bingham
NPI 1831425693
$7,470.25
in general payments reported to CMS, 2019-2025
7 companies · $109 in 2025
The $109 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,825 · 2022: $285 · 2023: $1,400 · 2024: $2,850 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,125 · Food and Beverage: $873 · Travel and Lodging: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,125.00 |
| Food and Beverage | $872.89 |
| Travel and Lodging | $361.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,500.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $1,969.68 | 2021-2025 | Koselugo |
| Otter Pharmaceuticals, LLC | $1,493.16 | 2024 | Sympazan |
| Springworks Therapeutics, INC. | $1,140.00 | 2024 | |
| Novocure INC. | $141.32 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $119.74 | 2021 | |
| Novartis Pharmaceuticals Corporation | $106.35 | 2021-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Racheal Bingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.